Page Title
01-03/05 04-06/05 07-09/05 10-12/05 13-15/05 16-18/05 19/05 20/05 21/05 22/05 23/05 24/05 25/05 26/05 27/05 28/05 29/05 30/05
US CA GB FR IT AU ZA AR CL MX ES NL NO CY JO DZ MA LB

The Mission of the organisation

Foster an international community

Foster an international community

Promote a global community of people affected by bladder cancer

Buildalliances

Buildalliances

Drive partnerships with health professionals, policy makers, academics, researchers and industry

Advocate for access

Advocate for access

Campaign for better bladder cancer‘information, support, and care

Governance

Governance

This organisation is governed by a board of directors, comprised of people diagnosed with bladder cancer, carers of people with bladder cancer or those engaged with bladder cancer organizations at a significant level.

First Word Bladder Cancer Patient Coalition meeting

The first World Bladder Cancer Patient Coalition Meeting took place on Monday 18 March 2019 from 12:00 until 17:00 in Barcelona, Spain. The second meeting will take place in late 2020 – to stay updated, make sure to subscribe to our newsletter!

The following organizations are members of the World Bladder Cancer Patient Coalition: 

 

 

 

Contact the WBCPC if you are interested in joining the Coalition, inquiring about its activities or supporting its mission.

Subscribe to the World Bladder Cancer Patient Coalition Newsletter

World Bladder Cancer Patient Coalition benefits from the support of F. Hoffman-La Roche AG, AstraZeneca, Bayer AG, Astellas Pharma, Bristol-Myers Squibb, Ipsen,  Janssen Pharmaceutica, Merck KgaA, MSD, Pfizer, Photocure and Seattle Genetics. The scope and content of this webpage are the sole responsibility of the World Bladder Cancer Patient Coalition.